Applegate, Robert J <br/><br/>
Bivalirudin and DES: a PCI strategy that pays.  [electronic resource] 

 -  The Journal of invasive cardiology  Feb 2007 
 - 69-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1557-2501 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticoagulants--adverse effects<br/>Coronary Artery Disease--therapy<br/>Costs and Cost Analysis<br/>Drug Delivery Systems<br/>Heparin--adverse effects<br/>Hirudins--adverse effects<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Length of Stay--economics<br/>Myocardial Infarction--drug therapy<br/>Paclitaxel--administration & dosage<br/>Peptide Fragments--adverse effects<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Recombinant Proteins--adverse effects<br/>Sirolimus--administration & dosage<br/>Stents--economics